In Vivo Pyruvate Detected by MR Spectroscopy in Neonatal Pyruvate Dehydrogenase Deficiency

References

1. ↵
   Brown GK, Otero LJ, LeGris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet 1994;21:875–879
2. ↵
   Shevell MI, Matthews PM, Scriver CR, et al. Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 1994;11:224–229

   CrossRefPubMedWeb of Science
3. ↵
   Cross JH, Connelly A, Gadian DG, et al. Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr Neurol 1994;10:276–283

   CrossRefPubMed
4. ↵
   Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 2001;56:1265–1272

   Abstract/FREE Full Text
5. Frahm J, Hanefeld F. Magnetic resonance spectroscopy and imaging in neurochemistry. In: Bachelard H, ed. Advances in Neurochemistry. New York: Plenum Press;1997 :371–375
6. ↵
   Michotte A, De Meirleir L, Lissens W, et al. Neuropathological findings of a patient with pyruvate dehydrogenase E1 alpha deficiency presenting as a cerebral lactic acidosis. Acta Neruopathol (Berl) 1993;85:674–678

   CrossRef
7. ↵
   Takahashi S, Oki J, Miyamoto A, et al. Autopsy findings in pyruvate dehydrogenase E1alpha deficiency: case report. J Child Neurol 1997;12:519–524

   CrossRefPubMedWeb of Science
8. ↵
   Jouet M, Rosenthal A, Armstrong G, et al. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 1994;7:402–407

   CrossRefPubMedWeb of Science
9. ↵
   Robinson JN, Norwitz ER, Mulkern R, Brown SA, Rybicki F, Tempany CM. Prenatal diagnosis of PDH deficiency using magnetic resonance imaging. Prenat Diagn 2001;21:1053–1056

   CrossRefPubMed
10. ↵
    Kok RD, van den Bergh AJ, Heerschap A, Nijland R, van den Berg PP. Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy. Am J Obstet Gynecol 2001;185:1011–1015

    CrossRefPubMed
11. ↵
    Fenton BW, Lin CS, Macedonia C, Schellinger D, Ascher S. The fetus at term: in utero volume-selected proton MR spectroscopy with a breath-hold technique: a feasibility study. Radiology 2001;219:563–566

    CrossRefPubMed
12. ↵
    Hooper SB, Walker DW, Harding R. Oxygen, glucose, and lactate uptake by fetus and placenta during prolonged hypoxemia. Am J Physiol 1995;268:R303–R309

    PubMed
13. ↵
    Yeung DK, Chan Y, Leung S, Poon PM, Pang C. Detection of an intense resonance at 2.4 ppm in 1H MR spectra of patients with severe late-delayed, radiation-induced brain injuries. Magn Reson Med 2001;45:994–1000

    CrossRefPubMed
14. ↵
    Wang ZJ, Zimmerman RA. Proton MR spectroscopy of pediatric brain metabolic disorders. Neuroimaging Clin N Am 1998;8:781–807

    PubMed
15. ↵
    Berry GT, Hunter JV, Wang Z, et al. In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy. J Pediatr 2001;138:260–262

    CrossRefPubMedWeb of Science
16. ↵
    Gabis L, Parton P, Roche P, Lenn N, Tudorica A, Huang W. In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia. J Neuroimaging 2001;11:209–211

    PubMed
17. ↵
    Takahashi S, Oki J, Miyamoto A, Okuno A. Proton magnetic resonance spectroscopy to study the metabolic changes in the brain of a patient with Leigh syndrome. Brain Dev 1999;21:200–204

    CrossRefPubMed
18. ↵
    Rubio-Gozalbo ME, Heerschap A, Trijbels JM, De Meirleir L, Thijssen HO, Smeitink JA. Proton MR spectroscopy in a child with pyruvate dehydrogenase complex deficiency. Magn Reson Imaging 1999;17:939–944

    CrossRefPubMed